Tetravac inj. susp. i.m. pre-filled syr.

Država: Belgija

Jezik: engleski

Izvor: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Kupi sada

Aktivni sastojci:

Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose; Diphtheria Toxoid (DT) >= 30 IU; Tetanus Toxoid >= 40 IU; Aluminium Hydroxide 0,3 mg; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Bordetella Pertussis Toxoid (PT) 25 µg; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg

Dostupno od:

Sanofi Pasteur Europe S.A.

ATC koda:

J07CA02

INN (International ime):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Farmaceutski oblik:

Suspension for injection

Sastav:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Administracija rute:

Intramuscular use

Područje terapije:

Diphtheria-Pertussis-Poliomyelitis-Tetanus

Proizvod sažetak:

CTI code: 196122-01 - Pack size: 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 196122-02 - Pack size: 0.5 ml - Commercialisation status: YES - FMD code: 03664798005219 - CNK code: 2231868 - Delivery mode: Medical prescription; CTI code: 196122-03 - Pack size: 0.5 ml + 1 x Injection needle - Commercialisation status: NO - Delivery mode: Medical prescription; 196122-04; 196122-05; 196122-06

Status autorizacije:

Commercialised: Yes

Datum autorizacije:

1998-11-03

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku njemački 28-03-2024
Uputa o lijeku Uputa o lijeku francuski 28-03-2024
Svojstava lijeka Svojstava lijeka francuski 28-03-2024
Uputa o lijeku Uputa o lijeku nizozemski 28-03-2024
Svojstava lijeka Svojstava lijeka nizozemski 28-03-2024